Trials / Completed
CompletedNCT02284282
Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Maasstad Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after surgery.
Detailed description
We expect that in laparoscopic gastro-intestinal surgery, a single shot spinal with bupicavaine/morphine will result in a better analgesia in hte first 48 hours. Herby the patients will require less systemic opioids, which will decrease the side-effects. Furthermore, we expect the patients to recover quicker and show an earlier mobilisation and a shorter hospital stay. The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spinal injection bupivacaine/morphine | Spinal injection bupivacaine/morphine in laparoscopic surgery |
| DRUG | subcutaneum injection lidocaine | placebo injection |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2014-11-06
- Last updated
- 2018-08-08
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02284282. Inclusion in this directory is not an endorsement.